Journal of Depression and Therapy
Open Access
Ketamine-Based Treatment of MDD: A Biologist’s Perspective
Aug 2017 DOI 10.14302/issn.2476-1710.jdt-17-1673
Shupeng LiCorresponding author
Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine’s effect, there are a few critical issues remained to be resolved. This mini re…